biosimilars
Boehringer to create biosimilars division
September 27, 2011Research and Development Boehringer, biosimilars
Boehringer Ingelheim is to tap into the growing interest in biosimilars with the creation of a division dedicated to that …
Samsung forges biosimilar venture with Quintiles
March 2, 2011Manufacturing and Production Quintiles, Samsung, biosimilar production, biosimilars, pharma production
South Korean electronics giant Samsung has formed a joint venture with Quintiles with the objective of breaking into the market …
Merck taps Parexel to help it meet biosimilar ambitions
January 18, 2011Research and Development Merck & Co, Parexel, biosimilars
Merck & Co has enlisted the aid of contract research organisation Parexel to help it develop biosimilar versions of some …
Biosimilars: the great balancing act
April 6, 2010Research and Development biogenerics, biosimilars
Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …
Healthcare reform momentus for pharma too
April 1, 2010Obama, US, biosimilars, healthcare reform
Historic reforms of America’s healthcare system have now passed into law, representing its most radical overhaul ever. Nevertheless, the bill …
Brennan rejects generics diversification model
February 11, 2010Sales and Marketing AstraZeneca, biosimilars, em, generics, industry
AstraZeneca’s chief executive David Brennan has rejected the strategy of diversification into generics and biosimilars being pursued by many of …
FDA to assess Neupogen biosimilar
February 3, 2010Research and Development, Sales and Marketing Hospira, Teva, biosimilars
US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …
Hospira takes charge of biogeneric Neupogen
October 14, 2009Sales and Marketing Hospira, biosimilars, generics
US pharmaceutical company Hospira has acquired worldwide rights to a biogeneric version of Amgen's neutropenia treatment Neupogen (filgrastim) in a …
Cipla plans push into biosimilars
September 10, 2009Sales and Marketing biosimilars, generics
Mumbai-based generics manufacturer Cipla is to begin making biosimilars, generic substitutable versions of branded biologic drugs. It plans to do …
Are biosimilars delivering the goods in the EU?
March 10, 2009Manufacturing and Production, Research and Development biosimilars
In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful …
Teva and Lonza join forces in biosimilars
January 21, 2009Sales and Marketing biosimilars, generics
Teva, the world's largest generics manufacturer, has teamed up with manufacturing specialist Lonza to exploit the market for biosimilar medicines. …
Latest news from Datamonitor
November 17, 2008Sales and Marketing biosimilars, generics
Key decision makers will shape the biosimilars landscapeWith many biologic drugs used to treat increasingly common diseases such as cancer …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
